This compound is primarily utilized in the field of medicinal chemistry and drug development due to its structural similarity to combretastatin, a well-known tubulin polymerization inhibitor. It is studied for its potential anticancer properties, particularly in targeting and disrupting the formation of microtubules in cancer cells, which can inhibit their proliferation and induce apoptosis. Researchers are also exploring its application in the synthesis of analogs for enhanced efficacy and reduced toxicity in cancer therapy. Additionally, its unique structure makes it a candidate for further investigation in the development of novel therapeutic agents for other diseases involving abnormal cell growth.